Impact BioMedical Statistics
Total Valuation
IBO has a market cap or net worth of $24.39 million. The enterprise value is $29.73 million.
| Market Cap | 24.39M |
| Enterprise Value | 29.73M |
Important Dates
The next estimated earnings date is Tuesday, March 4, 2025, before market open.
| Earnings Date | Mar 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IBO has 11.50 million shares outstanding. The number of shares has decreased by -14.00% in one year.
| Current Share Class | 11.50M |
| Shares Outstanding | 11.50M |
| Shares Change (YoY) | -14.00% |
| Shares Change (QoQ) | +620.17% |
| Owned by Insiders (%) | 0.85% |
| Owned by Institutions (%) | 2.26% |
| Float | 5.16M |
Valuation Ratios
The trailing PE ratio is 175.47.
| PE Ratio | 175.47 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.78 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 25.52 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.79, with a Debt / Equity ratio of 0.23.
| Current Ratio | 2.79 |
| Quick Ratio | 2.34 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.98 |
Financial Efficiency
Return on equity (ROE) is 3.45% and return on invested capital (ROIC) is -5.47%.
| Return on Equity (ROE) | 3.45% |
| Return on Assets (ROA) | -4.99% |
| Return on Invested Capital (ROIC) | -5.47% |
| Return on Capital Employed (ROCE) | -8.04% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $1.17M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.82 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 55.09 |
| Average Volume (20 Days) | 23,023 |
Short Selling Information
The latest short interest is 9,384, so 0.08% of the outstanding shares have been sold short.
| Short Interest | 9,384 |
| Short Previous Month | 6,299 |
| Short % of Shares Out | 0.08% |
| Short % of Float | 0.18% |
| Short Ratio (days to cover) | 0.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.66M |
| Pretax Income | -8.34M |
| Net Income | 1.17M |
| EBITDA | -3.66M |
| EBIT | -3.66M |
| Earnings Per Share (EPS) | $0.01 |
Balance Sheet
The company has $2.67 million in cash and $8.01 million in debt, giving a net cash position of -$5.34 million or -$0.46 per share.
| Cash & Cash Equivalents | 2.67M |
| Total Debt | 8.01M |
| Net Cash | -5.34M |
| Net Cash Per Share | -$0.46 |
| Equity (Book Value) | 34.35M |
| Book Value Per Share | 2.72 |
| Working Capital | 2.04M |
Cash Flow
| Operating Cash Flow | -3.10M |
| Capital Expenditures | n/a |
| Free Cash Flow | -3.10M |
| FCF Per Share | -$0.27 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IBO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 14.00% |
| Shareholder Yield | 14.00% |
| Earnings Yield | 4.78% |
| FCF Yield | -12.69% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |